SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007182
Filing Date
2021-05-14
Accepted
2021-05-14 09:58:58
Documents
119
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vreof-20210331x10q.htm   iXBRL 10-Q 1506057
2 EX-31.1 vreof-20210331xex31d1.htm EX-31.1 14231
3 EX-31.2 vreof-20210331xex31d2.htm EX-31.2 14219
4 EX-32.1 vreof-20210331xex32d1.htm EX-32.1 7809
5 EX-32.2 vreof-20210331xex32d2.htm EX-32.2 5566
  Complete submission text file 0001558370-21-007182.txt   8630657

Data Files

Seq Description Document Type Size
6 EX-101.SCH vreof-20210331.xsd EX-101.SCH 91497
7 EX-101.CAL vreof-20210331_cal.xml EX-101.CAL 72107
8 EX-101.DEF vreof-20210331_def.xml EX-101.DEF 243049
9 EX-101.LAB vreof-20210331_lab.xml EX-101.LAB 645918
10 EX-101.PRE vreof-20210331_pre.xml EX-101.PRE 515518
11 EXTRACTED XBRL INSTANCE DOCUMENT vreof-20210331x10q_htm.xml XML 1572852
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Health International, Inc. (Filer) CIK: 0001771706 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56225 | Film No.: 21922357
SIC: 2834 Pharmaceutical Preparations